Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.
Spago Nanomedical will participate in Avanza Börsdag, a collaboration between Avanza and Financial Hearings, on Wednesday November 28, 2018.
Mabtech, a worldwide supplier of kits and reagents for immune monitoring, today unveil a new revolutionary FluoroSpot & ELISpot reader called Mabtech IRIS™ with their R&D partner Qamcom Research and Technology Stockholm, a Technology Application Expert. Mabtech IRIS is a spot reader with precision and accuracy previously not available in the market, creating exciting new possibilities for the research community.
Spago Nanomedical has been granted 500 000 SEK by Sweden's government agency for innovation, Vinnova, to support the clinical development and commercialization of SpagoPix.